Compounded semaglutide is a customized version of the medication, prepared by our partner, Belmar Pharma Solutions. This GLP-1 receptor agonist helps manage type 2 diabetes and supports weight loss by regulating blood sugar and controlling appetite.

Glucagon-like Peptide-1 (GLP-1) is a hormone that helps regulate blood sugar levels and appetite. Medications that mimic GLP-1 are often used to treat type 2 diabetes and support weight loss by improving blood sugar control and reducing hunger.

Gastric Inhibitory Polypeptide (GIP) is a hormone that helps regulate insulin and blood sugar levels. Medications that mimic GIP are used to improve blood sugar control and may also support weight loss by enhancing the body's insulin response and regulating appetite.

Belmar Pharma Solutions is a compounding pharmacy that strictly adheres to industry regulations set by state boards of pharmacy, the FDA, and the DEA. They ensure the safety and quality of their ingredients and compounded medications, complying with USP <795> guidelines for non-sterile compounding. They also meet USP <800> standards for handling hazardous drugs, safeguarding our pharmacy personnel and environment. Their internal policies go beyond regulatory requirements, with rigorous testing conducted by an independent lab from sourcing to distribution. This commitment ensures the highest level of safety, accuracy, and quality for their compounded medications.

These medications are administered via a subcutaneous injection, which involves injecting the medication just under the skin. Your provider will give you detailed instructions on how to safely and properly administer these injections, including the correct technique, dosage, and injection sites to ensure optimal effectiveness and comfort.

Compounded drugs can be prescribed under federal law, though they are not specifically FDA-approved. Unlike standard medications, compounded drugs do not undergo the same FDA reviews for safety, effectiveness, or manufacturing. However, compounding pharmacies that follow strict regulations set by the state boards of pharmacy, FDA, and DEA are permitted to compound certain medications under the Drug Quality and Security Act (DQSA). This includes popular weight loss ingredients like semaglutide and tirzepatide, which meet federal guidelines for use.

The FDA permits compounding pharmacies to make compounded medications under specific circumstances, primarily outlined by the Drug Quality and Security Act (DQSA). Compounding is allowed when: Patient-Specific Needs: Compounded medications are created based on a prescription for an individual patient, often because commercially available drugs don't meet specific needs (e.g., different dosage, allergen-free formulation). Shortages or Unavailability: The FDA allows compounding if the commercially available medication is in shortage or temporarily unavailable. Regulatory Compliance: Compounding pharmacies must follow regulations set by state boards of pharmacy and adhere to federal guidelines for quality, including using FDA-approved active ingredients. 

Compounding must be done under the framework of either Section 503A (traditional compounding pharmacies) or Section 503B (outsourcing facilities) of the Federal Food, Drug, and Cosmetic Act. 

In short, compounded medications are not FDA-approved, but they are permitted as long as these guidelines are followed and are subject to oversight to ensure safety and quality.

Brand-name weight loss medications can be costly, often ranging from $1,000 to $1,500 out-of-pocket when insurance doesn’t cover them or requires a high co-pay. 

To make treatment more accessible, we've created programs that are both affordable and personalized to your unique needs.

Costs vary based on your specific program, but compounded semaglutide starts at $210 per month. Special promotional pricing is  exclusively for patients wishing to start Semaglutide for the first time. These patients are required to go through our initial dosing protocol. 

Pricing may vary if you are already taking Semaglutide  at a higher dosage prior to switching to our services or for patients who wish to stay on a month-to month maintenance dose after their initial three months promotional offer. Pricing per dose of Semaglutide is $229/month for 0.25 mg, $249/month for 0.5-1.0 mg, $259/month for 1.25 mg, $269/month for 1.5 mg, $299/month for 2-2.5 mg and $369/month for 3 mg. 

For more details on pricing, contact us at info@identidhealth.com or call (888) 383-8839.

There are no hidden fees with our weight loss subscriptions. For a 3-month plan, the price covers one monthly consultation (if needed), your custom treatment plan, medication, and delivery.

For month-to-month plans, the initial consultation is $50, but subsequent months include one consultation (if needed), your custom treatment plan, medication, and delivery. For more information on month to month pricing or for maintenance dose pricing after your initial three month committment, please visit identid.com/pricing/, email us at info@identidhealth.com, or call us at (888) 383-8839.